Scientists validated a previously identified biomarker of late radiation therapy (RT)-induced genitourinary (GU)toxicity, PROSTOX, consisting primarily of microRNA-based germline biomarkers (mirSNPs), and investigated the possibility of temporally and genetically defining other forms of RT-associated GU toxicity.
[Clinical Cancer Research]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News